Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria P Del Castillo-Frias

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based AssaysPhuong H Nguyen, Maria P Del Castillo-Frias, Olivia Berthoumieux, et al.
ACS Chemical Neuroscience|June 7, 2017
Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?Andrew J Doig, Maria P Del Castillo-Frias, Olivia Berthoumieu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 17, 2015
Combined experimental and simulation studies suggest a revised mode of action of the anti-Alzheimer disease drug NQ-TrpOlivia Berthoumieu, Phuong H Nguyen, Maria P Del Castillo-Frias, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based AssaysPhuong H Nguyen, Maria P Del Castillo-Frias, Olivia Berthoumieux, et al.
ACS Chemical Neuroscience|June 7, 2017
Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?Andrew J Doig, Maria P Del Castillo-Frias, Olivia Berthoumieu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 17, 2015
Combined experimental and simulation studies suggest a revised mode of action of the anti-Alzheimer disease drug NQ-TrpOlivia Berthoumieu, Phuong H Nguyen, Maria P Del Castillo-Frias, et al.
Pageof 1